IRIS
DI BENEDETTO, Antonino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.230
NA - Nord America 8.520
AS - Asia 4.951
SA - Sud America 1.689
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 6
Totale 26.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.371
RU - Federazione Russa 5.085
SG - Singapore 2.177
BR - Brasile 1.455
CN - Cina 1.443
IE - Irlanda 1.224
IT - Italia 1.217
SE - Svezia 1.090
DE - Germania 632
FR - Francia 578
HK - Hong Kong 491
UA - Ucraina 466
FI - Finlandia 262
GB - Regno Unito 252
VN - Vietnam 235
PL - Polonia 169
IN - India 124
BD - Bangladesh 75
AR - Argentina 73
CA - Canada 58
TR - Turchia 58
IQ - Iraq 57
MX - Messico 54
NL - Olanda 53
EC - Ecuador 50
BE - Belgio 46
ZA - Sudafrica 43
EG - Egitto 39
JP - Giappone 38
ES - Italia 30
AT - Austria 29
MA - Marocco 28
PK - Pakistan 26
CO - Colombia 24
UZ - Uzbekistan 24
CZ - Repubblica Ceca 23
ID - Indonesia 23
SA - Arabia Saudita 22
IR - Iran 18
VE - Venezuela 18
AZ - Azerbaigian 17
UY - Uruguay 17
DZ - Algeria 16
TN - Tunisia 14
IL - Israele 13
JM - Giamaica 13
PE - Perù 13
PY - Paraguay 13
JO - Giordania 12
CL - Cile 11
KE - Kenya 11
LT - Lituania 11
PH - Filippine 11
CH - Svizzera 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
KG - Kirghizistan 9
LB - Libano 9
CI - Costa d'Avorio 8
NP - Nepal 8
RO - Romania 8
BG - Bulgaria 7
KZ - Kazakistan 7
SN - Senegal 7
EU - Europa 6
GE - Georgia 6
GR - Grecia 6
KR - Corea 6
PA - Panama 6
SY - Repubblica araba siriana 6
GY - Guiana 5
LV - Lettonia 5
MY - Malesia 5
AL - Albania 4
AU - Australia 4
BH - Bahrain 4
EE - Estonia 4
HU - Ungheria 4
PS - Palestinian Territory 4
RS - Serbia 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
HN - Honduras 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
BY - Bielorussia 2
LU - Lussemburgo 2
MN - Mongolia 2
MU - Mauritius 2
QA - Qatar 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AO - Angola 1
Totale 26.566
Salva come PNG Salva come JPEG
Città #
Moscow 1.459
Singapore 1.225
Dublin 1.224
Ashburn 1.198
Chandler 977
Jacksonville 894
Dallas 823
Nyköping 549
Beijing 539
Hong Kong 489
San Jose 393
The Dalles 224
Princeton 213
Boardman 199
Cambridge 196
Los Angeles 195
Lauterbourg 191
Dearborn 175
Messina 171
Des Moines 163
Medford 156
Warsaw 154
Ann Arbor 147
Munich 126
São Paulo 120
Buffalo 99
New York 87
Bremen 73
Council Bluffs 69
Ho Chi Minh City 69
Jinan 67
Tianjin 67
Wilmington 63
Milan 62
Shenyang 58
Florence 55
Woodbridge 55
Frankfurt am Main 54
Redondo Beach 54
Turku 51
Rome 49
Guangzhou 46
Brussels 45
Lancaster 44
Orem 44
Santa Clara 44
Hanoi 42
San Mateo 41
Belo Horizonte 38
Catania 35
Rio de Janeiro 34
Düsseldorf 33
Tokyo 33
Cairo 32
Nanjing 29
Naples 28
Seattle 28
Chennai 27
Curitiba 27
Pune 27
Haikou 26
Zhengzhou 26
Hebei 25
Brooklyn 24
Chicago 24
Brasília 23
Houston 23
Johannesburg 23
London 23
Montreal 23
Quito 22
Baghdad 21
San Francisco 21
Shanghai 21
Tashkent 21
Porto Alegre 20
Salvador 20
Ningbo 19
Denver 18
Hangzhou 18
Helsinki 18
Shenzhen 18
Stockholm 18
Guayaquil 17
Washington 17
Boston 16
Manchester 16
Mexico City 16
Nuremberg 16
Olomouc 16
Vienna 16
Atlanta 15
Guarulhos 15
Hyderabad 15
Montevideo 15
Phoenix 15
Baku 14
Bologna 14
Goiânia 14
Recife 14
Totale 14.665
Salva come PNG Salva come JPEG
Nome #
VALUTAZIONE DEI LIVELLI DI LIPOPROTEINA(A) ED INSULINA DURANTE E DOPO LA GRAVIDANZA. DATI PRELIMINARI 879
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 243
1ST-PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN CYSTIC- FIBROSIS PATIENTS WITH DIFFERENT DEGREES OF GLUCOSE-TOLERANCE 231
Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria. 229
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 226
"Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. 226
Depressione, ansia e rabbia in soggetti affetti da diabete mellito di tipo 1 [Depression, anxiety and anger in patients with type 1 diabetes mellitus] 218
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 216
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 215
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 215
Personality, Alexithymia, and Anger in a sample of adults affected by Type 1 Juvenile-Onset Diabetes. 208
Italian risk factor-based screening for gestational diabetes. 207
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 205
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 203
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 202
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 201
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 200
Different concentration of human cord blood HMGB1 according to delivery and labour: A pilot study 199
Erectile dysfunction in compensated liver cirrhosis 198
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 197
High Prevalence of Arcobacter Carriage in Older Subjects with Type 2 Diabetes 195
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 194
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 191
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 190
Myo-inositol may prevent gestational diabetes in PCOS women 186
EFFETTO DEL POLIMORFISMO CETP TAQ1B SUL PROFILO LIPIDICO E SULLE SOTTOPOLAZIONI HDL NELLE DONNE CON E SENZA DIABETE DI TIPO 2 183
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 181
Effects of myo-inositol on glucose variability in women with gestational diabetes 181
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 178
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 177
C-reactive protein as an early predictor of gestational diabetes mellitus 175
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 170
APOLIPOPROTEIN A1 GENE PROMOTER POLYMORPHISM AND CORONARY HEART-DISEASE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS 168
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 167
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 166
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 165
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 165
Carotid atherosclerosis and lipid profile in a diabetic population: a retrospective evaluation 163
Nuove evidenze sul ruolo della supplementazione con inositolo nel diabete gestazionale 163
The complex interplay between clinical and person-centered diabetes outcomes in the two genders 163
Anti-p53 autoantibodies in patients with IDDM 161
Epatite C: un fattore di rischio per il diabete? 161
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 161
Age and metabolic control influence lens opacity in IDDM patients 160
Hypoplastic nails and brachydactyly in a girl with moderate acne and hirsutism 160
Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. 159
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 158
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 157
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 157
Correlates of total homocysteine plasma concentration in type 2 diabetes 156
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 156
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 155
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 154
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 153
High mobility group protein B1: a new biomarker of obesity in pregnant women? 152
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 151
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 149
Serum thyroid hormone autoantibodies in type 1 diabetes mellitus 149
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 148
GENDER DIFFERENCES IN THE RELATIONSHIP BETWEEN METABOLIC SYNDROME AND ANGER EXPRESSION. 148
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 147
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 147
Epatite C: un fattore di rischio per il diabete? 146
A multicenter Italian study on pregnancy outcome in women with diabetes 145
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 144
Alterazioni della funzione urodinamica nel diabete mellito di tipo 2 143
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica 143
Is diabetes mellitus a risk factor for HCV infection? 142
CAROTID ATHEROSCLEROSIS AND LIPID PROFILE IN A DIABETIC POPULATION: A RETROSPECTIVE EVALUATION 142
C-reactive protein as an early predictor of gestational diabetes mellitus. 142
Studio eco-strain degli effetti del trattamento con Genisteina sul ventricolo sinistro in donne in post-menopausa con sindome metabolica (Strain-Echo Assessment of Left Ventricular Effects of Genistein Treatment in Post-Menopausal Women with Metabolic Syndrome). 142
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 139
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 139
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 136
Fattori di rischio cardiovascolare lipidici e non lipidici in donne diabetiche di tipo 2 con e senza cardiopatia ischemica. 136
Relationship between serum erythropoietin levels and rT3, T4 concentrations in elderly patients with non-thyroidal illnesses 135
Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus 135
La disfunzione diastolica nel diabete gestazionale 135
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 135
Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic cystic fibrosis patients. 135
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey 135
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 135
EFFETTO DEL DIABETE E DELLA MENOPAUSA SUL PROFILO LIPIDICO E LA DISTRIBUZIONE DELLE SOTTOPOPOLAZIONI HDL NELLE DONNE 134
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 134
A computerized network of diabetes clinics as a tool for quality of care improvement: the experience of Club Diabete Sicili@ 134
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 134
The impact of clinical and psychological characteristics on alexithymia in type 1 diabetes 131
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 128
A preliminary study of the use of telemedicine system for monitoring diabetes during pregnancy 128
AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care 128
Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo Study 127
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 126
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 126
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 124
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 123
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 120
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 118
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 118
La disfunzione diastolica nel diabete gestazionale 117
Livelli plasmatici dei marcatori di flogosi nelle donne: influenza della menopausa e del diabete 117
Totale 16.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/20221.428 22 191 26 48 48 25 114 67 29 286 164 408
2022/20233.791 277 298 179 299 359 398 27 213 1.560 21 116 44
2023/2024991 80 157 65 124 74 160 35 58 0 40 6 192
2024/20254.262 58 60 96 259 193 162 80 875 1.076 257 437 709
2025/202611.792 602 818 819 738 909 2.659 1.491 1.497 1.547 477 235 0
Totale 26.831